## **Core Concept**
Type II lepra reaction, also known as erythema nodosum leprosum (ENL), is an immune-mediated complication that can occur in patients with multibacillary leprosy, particularly those with borderline lepromatous or lepromatous leprosy. It is characterized by the sudden appearance of tender skin nodules, fever, and systemic inflammation. Management of type II lepra reaction involves anti-inflammatory therapy in addition to continuing anti-leprosy multidrug therapy (MDT).

## **Why the Correct Answer is Right**
The correct approach to managing a type II lepra reaction in a patient on multidrug therapy for leprosy involves adding anti-inflammatory agents to control the reaction while continuing the MDT. Corticosteroids are the mainstay of treatment for type II lepra reactions due to their potent anti-inflammatory effects. Non-steroidal anti-inflammatory drugs (NSAIDs) may also be used for mild cases. The goal is to control the reaction and prevent tissue damage. Therefore, the next course of action would involve administering corticosteroids.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because simply continuing MDT without addressing the reaction would not be sufficient to manage the patient's condition. MDT is crucial for curing leprosy but does not directly treat the reaction.
- **Option B:** This option might seem plausible if it suggested adding a specific anti-inflammatory or immunosuppressive agent, but without specifics, it's hard to evaluate. However, if it implies stopping MDT, which is not recommended, then it's incorrect.
- **Option C:** This option is incorrect if it suggests discontinuing MDT, as MDT should be continued to ensure the patient is cured of leprosy. Stopping MDT could lead to drug resistance or treatment failure.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in managing type II lepra reactions, **corticosteroids** are the first line of treatment. It's also crucial to monitor for potential side effects of long-term corticosteroid use, such as osteoporosis and diabetes. MDT should be continued unless there are severe side effects that necessitate temporary cessation.

## **Correct Answer:** D. Administer corticosteroids.